Top pharma execs at the marquee companies don’t really retire. Some segue quite naturally into venture capital, where their contacts and heavyweight industry reputations can facilitate the growth of little biotech companies at a time the VC crowd is enjoying a prolonged and popular boom.
{iframe}https://endpts.com/ex-gsk-rd-chief-moncef-slaoui-is-going-biotech-vc-joining-medicxi-as-a-partner/{/iframe}